NEET-PG 2015 - Pharmacology Practice Questions

Q: What is a contraindication of antimuscarinic drugs?

Glaucoma. ***Correct: Glaucoma*** - Antimuscarinic drugs cause **mydriasis (pupil dilation)** and **cycloplegia**, which increases intraocular pressure, especially in individuals with **narrow-angle glaucoma**. - In narrow-angle glaucoma, pupil dilation causes the peripheral iris to bunch up and block the trabecular meshwork, obstructing aqueous humor outflow. - This can precipitate an **acute angle-closure glaucoma attack**, a medical emergency, making glaucoma an **absolute contraindication** to antimuscarinic drugs. - This is one of the most important contraindications to remember for all anticholinergic medications. *Incorrect: Peptic ulcer* - Antimuscarinic drugs were **historically used to treat** peptic ulcer disease by reducing gastric acid secretion and gastrointestinal motility. - While they are no longer first-line therapy (replaced by proton pump inhibitors and H2 blockers), peptic ulcer is **not a contraindication**. - The main reason they fell out of favor was due to side effects and less efficacy compared to modern alternatives, not because they worsen the condition. *Incorrect: Asthma* - Some antimuscarinics (e.g., **ipratropium, tiotropium**) are actually used as **bronchodilators** in asthma and COPD management. - They work by blocking muscarinic receptors in airway smooth muscle, causing bronchodilation. - Therefore, asthma is a **treatment indication**, not a contraindication. *Incorrect: Urinary incontinence* - Antimuscarinic drugs are the **primary pharmacological treatment** for overactive bladder and urge incontinence. - They work by blocking M3 muscarinic receptors in the detrusor muscle, reducing bladder contractions. - Common drugs include oxybutynin, tolterodine, and solifenacin. - Urinary incontinence is a **treatment indication**, not a contraindication.

Q: Maximum cycloplegic action of atropine is seen at ?

1-3 hours. ***1-3 hours*** - Atropine, a **non-selective muscarinic antagonist**, reaches its **peak cycloplegic effect** approximately 1 to 3 hours after topical administration. - This peak activity is crucial for accurate retinoscopy and **refractive error measurement** in children, as it effectively paralyzes the ciliary muscle. *4-6 hours* - While atropine's cycloplegic effect is still present at 4-6 hours, it is generally **past its peak action** by this time. - Slower-acting cycloplegics might have their peak around this window, but not atropine. *1-2 weeks* - The **duration of action** for atropine's cycloplegic and mydriatic effects can last for 1-2 weeks, but this is the total duration, not when the maximum action is observed. - Patients are often instructed about the **prolonged effects** and potential for blurred vision and photophobia over this period. *30-60 minutes* - While some mydriatic effects might start within 30-60 minutes, the **full cycloplegic effect** of atropine, which requires maximum paralysis of the ciliary muscle, is not achieved in this short timeframe. - Shorter-acting cycloplegics like **cyclopentolate** or **tropicamide** would show peak action within this earlier interval.

Q: Which of the following is NOT a side effect of atropine?

Diarrhoea. ***Diarrhoea*** - Atropine is a **muscarinic antagonist** that blocks the action of **acetylcholine** on muscarinic receptors in the gastrointestinal tract. - This leads to **decreased GI motility** and **decreased secretions**, typically causing **constipation**, NOT diarrhoea. - Diarrhoea would be associated with **cholinergic agonists** or anticholinesterases, which increase GI motility. *Blurring of vision* - Atropine causes **mydriasis** (pupil dilation) and **cycloplegia** (paralysis of the ciliary muscle). - **Cycloplegia** impairs accommodation for near vision, leading to **blurring of vision**. - This is a common anticholinergic side effect. *Urinary retention* - Atropine blocks **M3 receptors** on the **detrusor muscle**, causing bladder relaxation and reduced contractility. - This leads to **urinary retention**, especially in patients with pre-existing conditions like **prostatic hypertrophy**. *Confusion in elderly* - Atropine can cross the **blood-brain barrier** and cause **CNS effects** including confusion, agitation, and delirium. - Elderly patients are particularly susceptible to these **central anticholinergic effects**.

Q: Which is the longest acting anti-cholinesterase?

Echothiophate. ***Echothiophate*** - **Echothiophate** is an **organophosphate** compound that irreversibly inhibits acetylcholinesterase, leading to a prolonged duration of action, often measured in weeks. - Due to its **long-acting** and irreversible nature, it is primarily used in ophthalmic preparations for glaucoma but is not commonly used systemically. *Pyridostigmine* - **Pyridostigmine** is a medium-acting anticholinesterase, typically lasting **3-6 hours**, and is commonly used for the chronic management of **myasthenia gravis**. - Its effects are **reversible**, binding to the enzyme for a limited period. *Ambenonium* - **Ambenonium** has a longer duration of action than pyridostigmine, typically lasting **4-8 hours**, but is still considered a reversible inhibitor. - It was historically used for **myasthenia gravis** but is now less common due to the availability of other effective treatments. *Edrophonium* - **Edrophonium** is a very short-acting anticholinesterase, with effects lasting only **5-15 minutes**, making it ideal for the **Tensilon test** to diagnose myasthenia gravis and differentiate between myasthenic and cholinergic crises. - Its rapid onset and brief duration are due to its **reversible** and transient binding to acetylcholinesterase.

Q: Propranolol is most commonly prescribed as first-line therapy for which condition?

Thyrotoxicosis (excessive thyroid hormones). ***Thyrotoxicosis (excessive thyroid hormones)*** - **Propranolol** is commonly prescribed as **first-line symptomatic therapy** for **thyrotoxicosis** to manage symptoms such as **tachycardia, tremors, palpitations, and anxiety**. - It works by **blocking peripheral conversion of T4 to T3** and providing rapid **symptomatic relief** through beta-blockade. - While it does not treat the underlying thyroid disorder, it is the **immediate first-line agent** for symptom control while definitive treatment (antithyroid drugs, radioiodine, or surgery) is being arranged. - **Clinical pearl:** Propranolol is preferred over selective beta-blockers due to its additional effect on T4 to T3 conversion. *Hypertension (high blood pressure)* - **Propranolol** is **NOT a first-line agent** for hypertension in current guidelines (JNC 8, ESC/ESH). - First-line agents include **ACE inhibitors, ARBs, thiazide diuretics, and calcium channel blockers**. - Non-selective beta-blockers like propranolol are typically **third-line or later** due to unfavorable metabolic effects and side effect profile. - Selective beta-blockers (atenolol, metoprolol) may be used in specific hypertension scenarios, but propranolol is rarely first-line. *Atrioventricular (AV) block* - **Propranolol** is **absolutely contraindicated** in **AV block** as it further slows conduction through the AV node. - Beta-blockers can precipitate **complete heart block** in patients with pre-existing conduction abnormalities. *Cardiac arrest* - **Propranolol** is **contraindicated** in acute management of **cardiac arrest** as it reduces cardiac contractility and can worsen outcomes. - Cardiac arrest management involves **CPR, defibrillation, epinephrine, and amiodarone**.

Q: Which diuretic is known to cause the maximum potassium loss?

Furosemide. ***Furosemide*** - Furosemide is a **loop diuretic** that inhibits the Na-K-2Cl cotransporter in the **thick ascending limb of the loop of Henle**, leading to significant excretion of sodium, chloride, potassium, and water. - Its potent diuresis and impact on potassium reabsorption result in a **high risk of hypokalemia**. *Thiazide* - Thiazide diuretics inhibit the **Na-Cl cotransporter** in the **distal convoluted tubule**, causing moderate sodium and water excretion, and some potassium loss. - While they can cause hypokalemia, their effect on potassium excretion is generally **less pronounced than loop diuretics**. *Acetazolamide* - Acetazolamide is a **carbonic anhydrase inhibitor** that acts primarily in the **proximal tubule**, inhibiting bicarbonate reabsorption and leading to increased excretion of bicarbonate, sodium, potassium, and water. - The potassium loss is due to increased delivery of sodium to the collecting duct, leading to enhanced potassium secretion, but it is typically **less severe than with loop diuretics**. *Spironolactone* - Spironolactone is a **potassium-sparing diuretic** that acts as an **aldosterone antagonist** in the collecting duct, inhibiting sodium reabsorption and potassium secretion. - Instead of causing potassium loss, spironolactone actually **conserves potassium** and can lead to hyperkalemia.

Q: Hyoscine is an antagonist at which cholinergic receptor?

Muscarinic. ***Muscarinic*** - **Hyoscine** (scopolamine) is a well-known **antagonist** at **muscarinic cholinergic receptors**. - It blocks the action of **acetylcholine** at these receptors, leading to its anticholinergic effects like treating motion sickness and reducing secretions. *Nicotinic* - **Hyoscine** does not primarily act on **nicotinic cholinergic receptors**. - Drugs acting on nicotinic receptors include **neuromuscular blockers** (e.g., succinylcholine, rocuronium) and **ganglionic blockers**, which have different clinical applications. *Both* - While some drugs may have activity at both receptor types, **hyoscine's primary and clinically significant antagonism is at muscarinic receptors**. - Its therapeutic effects are attributed almost exclusively to its **muscarinic blockade**. *None of the above* - This option is incorrect because **hyoscine is a clear antagonist at muscarinic cholinergic receptors**. - Its widespread use in medicine is based on this specific pharmacological action.

Q: Fenoldopam is used in the management of?

Hypertensive emergencies. ***Hypertensive emergencies*** - **Fenoldopam** is a **dopamine D1 receptor agonist** that causes rapid, dose-dependent peripheral vasodilation and increased renal blood flow, making it suitable for acute blood pressure reduction during hypertensive emergencies. - Its **rapid onset** and short half-life allow for precise control of blood pressure, and its **benefit** in preserving or improving renal function is particularly beneficial in patients with renal impairment. *Congestive heart failure* - While fenoldopam can increase renal blood flow, it is not a primary treatment for **congestive heart failure (CHF)** and is not typically used for its management. - Other drug classes, such as **diuretics**, **ACE inhibitors**, and **beta-blockers**, are the mainstays of CHF treatment. *Migraine prophylaxis* - Fenoldopam has **no role** in the prevention or acute treatment of migraines. - **Beta-blockers**, **calcium channel blockers**, and certain **antidepressants** are commonly used for migraine prophylaxis. *Tachyarrhythmias* - Fenoldopam **does not have antiarrhythmic properties** and is not indicated for the treatment of tachyarrhythmias. - **Beta-blockers**, **calcium channel blockers**, and specific **antiarrhythmic drugs** are used to manage tachyarrhythmias.

Q: Which of the following is not a known side effect of amiodarone?

Hyperglycemia. ***Hyperglycemia*** - **Hyperglycemia** is generally **not recognized** as a direct or common side effect of amiodarone. - Amiodarone's primary action is on cardiac ion channels, and its metabolic effects typically involve thyroid function, not glucose regulation. *Hyperthyroidism* - Amiodarone contains **iodine**, which can induce **thyroid dysfunction**, including both hypo- and hyperthyroidism. - **Amiodarone-induced hyperthyroidism (AIH)** can occur due to increased thyroid hormone synthesis or destructive thyroiditis. *Peripheral neuropathy* - **Neurological side effects**, including **peripheral neuropathy**, are known to occur with chronic amiodarone use. - Symptoms often include **paresthesias**, weakness, and sensory loss in the extremities. *Skin discoloration* - Prolonged use of amiodarone can lead to **bluish-gray skin discoloration**, particularly in sun-exposed areas. - This is due to the **accumulation of amiodarone** and its metabolites in the skin.

Q: Beta-blockers should be used with caution in patients with?

Conduction defect. ***Conduction defect*** - Beta-blockers **slow heart rate** and **decrease AV nodal conduction**, which can worsen pre-existing conduction defects like **AV block** or **sick sinus syndrome**. - Their use can lead to **symptomatic bradycardia** or complete heart block in susceptible individuals. - This represents a **strong relative contraindication** requiring significant caution. *Hypertension* - Beta-blockers are a **first-line treatment for hypertension**, effectively lowering blood pressure by reducing cardiac output and renin release. - They are generally **well-tolerated** and beneficial in most hypertensive patients. *Glaucoma* - Topical beta-blockers, such as **timolol**, are a common treatment for open-angle glaucoma as they **reduce aqueous humor production**, thereby lowering intraocular pressure. - Systemic use of beta-blockers does not typically worsen glaucoma and may even offer some benefit. *CHF* - While certain beta-blockers (**carvedilol, metoprolol succinate, bisoprolol**) are now proven beneficial in **chronic heart failure with reduced ejection fraction (HFrEF)**, they do require careful use. - They must be **initiated at low doses and carefully titrated** to avoid acute decompensation, and are **contraindicated in acute decompensated heart failure**. - However, **conduction defects** represent a **stronger contraindication** where beta-blockers can cause life-threatening bradycardia or complete heart block, making it the best answer for conditions requiring the most caution.

Question 1

What is a contraindication of antimuscarinic drugs?

Accepted Answer

Glaucoma

Answer

Peptic ulcer

Answer

Asthma

Answer

Urinary incontinence

Question 2

Maximum cycloplegic action of atropine is seen at ?

Accepted Answer

1-3 hours

Answer

1-2 weeks

Answer

4-6 hours

Answer

30-60 minutes

Question 3

Which of the following is NOT a side effect of atropine?

Accepted Answer

Diarrhoea

Answer

Urinary retention

Answer

Confusion of elderly

Answer

Blurring of vision

Question 4

Which is the longest acting anti-cholinesterase?

Accepted Answer

Echothiophate

Answer

Pyridostigmine

Answer

Ambenonium

Answer

Edrophonium

Question 5

Propranolol is most commonly prescribed as first-line therapy for which condition?

Accepted Answer

Thyrotoxicosis (excessive thyroid hormones)

Answer

Atrioventricular (AV) block

Answer

Hypertension (high blood pressure)

Answer

Cardiac arrest

Question 6

Which diuretic is known to cause the maximum potassium loss?

Accepted Answer

Furosemide

Answer

Spironolactone

Answer

Thiazide diuretics

Answer

Acetazolamide

Question 7

Hyoscine is an antagonist at which cholinergic receptor?

Accepted Answer

Muscarinic

Answer

Nicotinic

Answer

Both

Answer

None of the above

Question 8

Fenoldopam is used in the management of?

Accepted Answer

Hypertensive emergencies

Answer

Congestive heart failure

Answer

Migraine prophylaxis

Answer

Tachyarrhythmias

Question 9

Which of the following is not a known side effect of amiodarone?

Accepted Answer

Hyperglycemia

Answer

Peripheral neuropathy

Answer

Hyperthyroidism

Answer

Skin discoloration

Question 10

Beta-blockers should be used with caution in patients with?

Accepted Answer

Conduction defect

Answer

Hypertension

Answer

CHF

Answer

Glaucoma

NEET-PG 2015 — Pharmacology